Larimar Therapeutics Inc (LRMR)
6.86
-0.18
(-2.49%)
USD |
NASDAQ |
Jun 26, 11:39
Larimar Therapeutics Shareholders Equity (Quarterly): 230.84M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 230.84M |
| December 31, 2023 | 81.72M |
| September 30, 2023 | 92.71M |
| June 30, 2023 | 99.93M |
| March 31, 2023 | 106.24M |
| December 31, 2022 | 110.90M |
| September 30, 2022 | 118.66M |
| June 30, 2022 | 50.06M |
| March 31, 2022 | 57.10M |
| Date | Value |
|---|---|
| December 31, 2021 | 64.41M |
| September 30, 2021 | 72.07M |
| June 30, 2021 | 67.52M |
| March 31, 2021 | 78.78M |
| December 31, 2020 | 89.69M |
| September 30, 2020 | 102.64M |
| June 30, 2020 | 112.54M |
| December 31, 2019 | -0.694M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.694M
Minimum
Dec 2019
230.84M
Maximum
Mar 2024
90.30M
Average
89.69M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
| Biogen Inc | 15.21B |
| Eli Lilly and Co | 12.81B |
| PTC Therapeutics Inc | -893.92M |
| Design Therapeutics Inc | 269.56M |
| CEL-SCI Corp | 14.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 248.20M |
| Total Liabilities (Quarterly) | 17.36M |